These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7763298)

  • 1. The enigmatic catalytic mechanism of active-site serine beta-lactamases.
    Galleni M; Lamotte-Brasseur J; Raquet X; Dubus A; Monnaie D; Knox JR; Frère JM
    Biochem Pharmacol; 1995 May; 49(9):1171-8. PubMed ID: 7763298
    [No Abstract]   [Full Text] [Related]  

  • 2. β-Lactamases: Why and How.
    Pratt RF
    J Med Chem; 2016 Sep; 59(18):8207-20. PubMed ID: 27232275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial DD-transpeptidases and penicillin.
    Jamin M; Wilkin JM; Frère JM
    Essays Biochem; 1995; 29():1-24. PubMed ID: 9189711
    [No Abstract]   [Full Text] [Related]  

  • 4. Binding of cephalothin and cefotaxime to D-ala-D-ala-peptidase reveals a functional basis of a natural mutation in a low-affinity penicillin-binding protein and in extended-spectrum beta-lactamases.
    Kuzin AP; Liu H; Kelly JA; Knox JR
    Biochemistry; 1995 Jul; 34(29):9532-40. PubMed ID: 7626623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics.
    Medeiros AA
    Clin Infect Dis; 1997 Jan; 24 Suppl 1():S19-45. PubMed ID: 8994778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-lactamases and bacterial resistance to antibiotics.
    Frère JM
    Mol Microbiol; 1995 May; 16(3):385-95. PubMed ID: 7565100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended-spectrum and inhibitor-resistant TEM-type beta-lactamases: mutations, specificity, and three-dimensional structure.
    Knox JR
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2593-601. PubMed ID: 8592985
    [No Abstract]   [Full Text] [Related]  

  • 8. [Functional and molecular classification of beta-lactamases].
    Arakawa Y
    Nihon Saikingaku Zasshi; 1999 Aug; 54(3):639-49. PubMed ID: 10502950
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular evolution of bacterial beta-lactam resistance.
    Knox JR; Moews PC; Frere JM
    Chem Biol; 1996 Nov; 3(11):937-47. PubMed ID: 8939710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic diversity of beta-lactamases.
    Frère JM; Dubus A; Galleni M; Matagne A; Amicosante G
    Biochem Soc Trans; 1999 Feb; 27(2):58-63. PubMed ID: 10093707
    [No Abstract]   [Full Text] [Related]  

  • 11. The importance of the negative charge of beta-lactam compounds in the interactions with active-site serine DD-peptidases and beta-lactamases.
    Varetto L; De Meester F; Monnaie D; Marchand-Brynaert J; Dive G; Jacob F; Frère JM
    Biochem J; 1991 Sep; 278 ( Pt 3)(Pt 3):801-7. PubMed ID: 1898366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Beta-lactamase inhibitors].
    Nishiya H; Kunii O
    Nihon Rinsho; 1991 Sep; 49(9):2046-51. PubMed ID: 1960873
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent advances in the chemistry of beta-lactam compounds as selected active-site serine beta-lactamase inhibitors.
    Mascaretti OA; Danelon GO; Laborde M; Mata EG; Setti EL
    Curr Pharm Des; 1999 Nov; 5(11):939-53. PubMed ID: 10539998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclobutanone analogues of beta-lactams revisited: insights into conformational requirements for inhibition of serine- and metallo-beta-lactamases.
    Johnson JW; Gretes M; Goodfellow VJ; Marrone L; Heynen ML; Strynadka NC; Dmitrienko GI
    J Am Chem Soc; 2010 Mar; 132(8):2558-60. PubMed ID: 20141132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural similarity of D-aminopeptidase to carboxypeptidase DD and beta-lactamases.
    Asano Y; Kato Y; Yamada A; Kondo K
    Biochemistry; 1992 Mar; 31(8):2316-28. PubMed ID: 1540587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SHV-type beta-lactamases.
    Tzouvelekis LS; Bonomo RA
    Curr Pharm Des; 1999 Nov; 5(11):847-64. PubMed ID: 10539992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spirocyclopropyl beta-lactams as mechanism-based inhibitors of serine beta-lactamases. Synthesis by rhodium-catalyzed cyclopropanation of 6-diazopenicillanate sulfone.
    Sandanayaka VP; Prashad AS; Yang Y; Williamson RT; Lin YI; Mansour TS
    J Med Chem; 2003 Jun; 46(13):2569-71. PubMed ID: 12801220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure, Function of Serine and Metallo-β-lactamases and their Inhibitors.
    Salahuddin P; Kumar A; Khan AU
    Curr Protein Pept Sci; 2018; 19(2):130-144. PubMed ID: 28745223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the origin of bacterial resistance to penicillin: comparison of a beta-lactamase and a penicillin target.
    Kelly JA; Dideberg O; Charlier P; Wery JP; Libert M; Moews PC; Knox JR; Duez C; Fraipont C; Joris B
    Science; 1986 Mar; 231(4744):1429-31. PubMed ID: 3082007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Lactamases: A Focus on Current Challenges.
    Bonomo RA
    Cold Spring Harb Perspect Med; 2017 Jan; 7(1):. PubMed ID: 27742735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.